Compare CPRX & NTSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRX | NTSK |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 2006 | N/A |
| Metric | CPRX | NTSK |
|---|---|---|
| Price | $31.49 | $13.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | ★ $35.00 | $18.19 |
| AVG Volume (30 Days) | 2.0M | ★ 6.3M |
| Earning Date | 05-11-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $119,072,803.00 | N/A |
| Revenue This Year | $9.20 | $25.76 |
| Revenue Next Year | $10.51 | $22.02 |
| P/E Ratio | $62.98 | ★ N/A |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $7.67 |
| 52 Week High | $32.56 | $24.98 |
| Indicator | CPRX | NTSK |
|---|---|---|
| Relative Strength Index (RSI) | 70.31 | 66.20 |
| Support Level | $31.25 | $8.67 |
| Resistance Level | $32.56 | $16.75 |
| Average True Range (ATR) | 0.04 | 0.91 |
| MACD | -0.05 | 0.32 |
| Stochastic Oscillator | 86.96 | 67.95 |
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.